Federal Register / Vol. 80, No. 48 / Thursday, March 12, 2015 / Notices 13035 

ATTACHMENT 1—GENERAL TARGET SCHEDULE FOR PROCESSING AND RESOLVING REQUESTS FOR ACCESS TO SENSITIVE

UNCLASSIFIED NON-SAFEGUARDS INFORMATION IN THIS PROCEEDING—Continued 

Day Event/Activity 

20 ................. U.S. Nuclear Regulatory Commission (NRC) staff informs the requester of the staff’s determination whether the request for access provides a reasonable basis to believe standing can be established and shows need for SUNSI. (NRC staff also informs 

any party to the proceeding whose interest independent of the proceeding would be harmed by the release of the information.) 

If NRC staff makes the finding of need for SUNSI and likelihood of standing, NRC staff begins document processing (preparation of redactions or review of redacted documents). 

25 ................. If NRC staff finds no ‘‘need’’ or no likelihood of standing, the deadline for petitioner/requester to file a motion seeking a ruling to 

reverse the NRC staff’s denial of access; NRC staff files copy of access determination with the presiding officer (or Chief Administrative Judge or other designated officer, as appropriate). If NRC staff finds ‘‘need’’ for SUNSI, the deadline for any party 

to the proceeding whose interest independent of the proceeding would be harmed by the release of the information to file a 

motion seeking a ruling to reverse the NRC staff’s grant of access. 

30 ................. Deadline for NRC staff reply to motions to reverse NRC staff determination(s). 

40 ................. (Receipt +30) If NRC staff finds standing and need for SUNSI, deadline for NRC staff to complete information processing and 

file motion for Protective Order and draft Non-Disclosure Affidavit. Deadline for applicant/licensee to file Non-Disclosure Agreement for SUNSI. 

A ................... If access granted: Issuance of presiding officer or other designated officer decision on motion for protective order for access to 

sensitive information (including schedule for providing access and submission of contentions) or decision reversing a final adverse determination by the NRC staff. 

A + 3 ............ Deadline for filing executed Non-Disclosure Affidavits. Access provided to SUNSI consistent with decision issuing the protective 

order. 

A + 28 .......... Deadline for submission of contentions whose development depends upon access to SUNSI. However, if more than 25 days remain between the petitioner’s receipt of (or access to) the information and the deadline for filing all other contentions (as established in the notice of hearing or opportunity for hearing), the petitioner may file its SUNSI contentions by that later deadline. 

A + 53 .......... (Contention receipt +25) Answers to contentions whose development depends upon access to SUNSI. 

A + 60 .......... (Answer receipt +7) Petitioner/Intervener reply to answers. 

>A + 60 ........ Decision on contention admission. 

[FR Doc. 2015–05679 Filed 3–11–15; 8:45 am] 

BILLING CODE 7590–01–P 

NUCLEAR REGULATORY 

COMMISSION 

[Docket No. 52–046; NRC–2015–0021] 

Korea Hydro and Nuclear Power Co., 

Ltd., and Korea Electric Power 

Corporation 

AGENCY: Nuclear Regulatory 

Commission. 

ACTION: Notice of docketing. 

SUMMARY: The U.S. Nuclear Regulatory 

Commission (NRC) has determined that 

Korea Hydro and Nuclear Power Co., 

Ltd. (KHNP) and Korea Electric Power 

Corporation (KEPCO) have submitted 

information for a standard design 

certification of the APR1400 Standard 

Plant Design that is acceptable for 

docketing. The docket number 

established is 52–046. 

DATES: March 12, 2015. 

ADDRESSES: Please refer to Docket ID 

NRC–2015–0021 when contacting the 

NRC about the availability of 

information regarding this document. 

You may obtain publicly-available 

information related to this document 

using any of the following methods: 

• Federal Rulemaking Web site: Go to 

http://www.regulations.gov and search 

for Docket ID NRC–2015–0021. Address 

questions about NRC dockets to Carol 

Gallagher; telephone: 301–415–3463; 

email: Carol.Gallagher@nrc.gov. For 

technical questions, contact the 

individual listed in the FOR FURTHER

INFORMATION CONTACT section of this 

document. 

• NRC’S Agencywide Documents 

Access and Management System 

(ADAMS): You may obtain publiclyavailable documents online in the 

ADAMS Public Documents collection at 

http://www.nrc.gov/reading-rm/ 

adams.html. To begin the search, select 

‘‘ADAMS Public Documents’’ and then 

select ‘‘Begin Web-based ADAMS 

Search.’’ For problems with ADAMS, 

please contact the NRC’s Public 

Document Room (PDR) reference staff at 

1–800–397–4209, 301–415–4737, or by 

email to pdr.resource@nrc.gov. The 

ADAMS accession number for each 

document referenced in this document 

(if that document is available in 

ADAMS) is provided the first time that 

the document is referenced. The 

application is available in ADAMS 

under Accession No. ML15006A037. 

• NRC’s PDR: You may examine and 

purchase copies of public documents at 

the NRC’s PDR, Room O1–F21, One 

White Flint North, 11555 Rockville 

Pike, Rockville, Maryland 20852. 

FOR FURTHER INFORMATION CONTACT: 

Jeffrey Ciocco, Office of New Reactors, 

U.S. Nuclear Regulatory Commission, 

Washington, DC, 20555–0001; 

telephone: 301–415–6391; email: 

Jeff.Ciocco@nrc.gov. 

SUPPLEMENTARY INFORMATION: By letter 

dated December 23, 2014, KHNP and 

KEPCO filed with the NRC, pursuant to 

Section 103 of the Atomic Energy Act 

and part 52 of Title 10 of the Code of 

Federal Regulations (10 CFR), 

‘‘Licenses, Certifications, and Approvals 

for Nuclear Power Plants,’’ an 

application for standard design 

certification of the APR1400 Standard 

Plant Design. A notice of receipt for this 

application was previously published in 

the Federal Register on February 3, 

2015 (80 FR 5792). 

The APR1400 stands for Advanced 

Power Reactor with a 1,400 megawatts 

electrical power and two-loop 

pressurized water reactor, developed in 

the Republic of Korea. According to the 

applicant, based on the self-reliant 

technologies and experiences from the 

design, construction, operation and 

maintenance of the Optimized Power 

Reactor 1000 (OPR1000), the APR1400 

adopts advanced design features to 

enhance plant safety, economical 

efficiency, and convenience of operation 

and maintenance. The APR1400 

application includes the entire power 

generation complex, except those 

elements and features considered sitespecific. 

The NRC staff has determined that 

KHNP and KEPCO have submitted 

information in accordance with 10 CFR 


asabaliauskas on DSK5VPTVN1PROD with NOTICES
13036 Federal Register / Vol. 80, No. 48 / Thursday, March 12, 2015 / Notices 

part 2, ‘‘Rules of Practice for Domestic 

Licensing Proceedings and Issuance of 

Orders,’’ and 10 CFR part 52 that is 

acceptable for docketing. The docket 

number established for this application 

is 52–046. 

The NRC staff will perform a detailed 

technical review of the design 

certification application. Docketing of 

the design certification application does 

not preclude the NRC from requesting 

additional information from the 

applicant as the review proceeds, nor 

does it predict whether the NRC will 

grant or deny the application. A notice 

related to the rulemaking pursuant to 10 

CFR 52.51 for design certification, 

including provisions for participation of 

the public and other parties, will be the 

subject of a subsequent Federal Register 

notice. 

Dated at Rockville, Maryland, this 3rd day 

of March, 2015. 

For the Nuclear Regulatory Commission. 

Jeffrey A. Ciocco, 

Senior Project Manager, Licensing Branch 2, 

Division of New Reactor Licensing, Office of 

New Reactors. 

[FR Doc. 2015–05579 Filed 3–11–15; 8:45 am] 

BILLING CODE 7590–01–P 

NUCLEAR REGULATORY 

COMMISSION 

[Docket No. 50–608; NRC–2013–0053] 

SHINE Medical Technologies, Inc.; 

Notice of Hearing, Opportunity To 

Intervene, Order Imposing Procedures 

AGENCY: Nuclear Regulatory 

Commission. 

ACTION: Construction permit 

application; hearing, opportunity to 

petition for leave to intervene; order 

imposing procedures for access to 

Sensitive Unclassified Non-Safeguards 

Information (SUNSI). 

SUMMARY: The U.S. Nuclear Regulatory 

Commission (NRC) has received a 

construction permit application from 

SHINE Medical Technologies, Inc. 

(SHINE), for approval of a proposed 

medical radioisotope production facility 

for the production of molybdenum-99 

(Mo-99) at a site located in Janesville, 

Wisconsin. The NRC is currently 

conducting a detailed technical review 

of the construction permit application. 

If the construction permit application is 

approved, the applicant would be 

authorized to construct its proposed 

medical radioisotope production facility 

in accordance with the provisions of the 

construction permit. 

DATES: A petition for leave to intervene 

must be filed by May 11, 2015. 

ADDRESSES: Please refer to Docket 

Number 50–608 or Docket ID NRC– 

2013–0053 when contacting the NRC 

about the availability of information 

regarding this document. You may 

obtain publicly-available information 

related to this document using any of 

the following methods: 

• NRC’s Agencywide Documents 

Access and Management System 

(ADAMS): You may obtain publicly 

available documents online in the 

ADAMS Public Documents collection at 

http://www.nrc.gov/reading-rm/

adams.html. To begin the search, select 

‘‘ADAMS Public Documents’’ and then 

select ‘‘Begin Web-based ADAMS 

Search.’’ For problems with ADAMS, 

please contact the NRC’s Public 

Document Room (PDR) reference staff at 

1–800–397–4209, 301–415–4737, or by 

email to pdr.resource@nrc.gov. The 

ADAMS accession number for each 

document referenced in this document 

(if that document is available in 

ADAMS) is provided the first time that 

a document is referenced. 

• NRC’s PDR: You may examine and 

purchase copies of public documents at 

the NRC’s PDR, Room O1–F21, One 

White Flint North, 11555 Rockville 

Pike, Rockville, Maryland 20852. 

FOR FURTHER INFORMATION CONTACT: 

Steven Lynch, Office of Nuclear Reactor 

Regulation, U.S. Nuclear Regulatory 

Commission, Washington, DC 20555– 

0001; telephone: 301–415–1524, email: 

Steven.Lynch@nrc.gov. 

SUPPLEMENTARY INFORMATION: 

I. Introduction 

By letters dated March 26, 2013 

(ADAMS Accession No. ML13088A192), 

and May 31, 2013 (ADAMS Accession 

No. ML13172A361), and supplemented 

by letter dated September 25, 2013 

(ADAMS Accession No. ML13269A378), 

SHINE requested approval of a 

construction permit application for a 

medical radioisotope production facility 

(ADAMS Accession No. ML13172A324). 

SHINE’s medical radioisotope 

production facility would include an 

irradiation facility and a radioisotope 

production facility collocated in a single 

building. The irradiation facility would 

consist of accelerator-driven subcritical 

operating assemblies used for the 

irradiation of a uranium solution to 

produce molybdenum-99 and other 

fission products. The radioisotope 

production facility would consist of hot 

cell structures used for the extraction of 

radioisotopes. Part one of the 

application was accepted for docketing 

on June 25, 2013 (78 FR 39342). The 

second and final portion of SHINE’s 

two-part construction permit 

application, as supplemented, was 

accepted for docketing on December 2, 

2013 (78 FR 73897). The docket number 

established for this application is 50– 

608. 

The NRC is considering issuance of a 

construction permit to SHINE for 

construction of the SHINE medical 

radioisotope production facility, to be 

located in Rock County, Wisconsin. 

II. Hearing 

Pursuant to the Atomic Energy Act of 

1954, as amended, and parts 2 and 50 

of Title 10 of the Code of Federal 

Regulations (10 CFR), ‘‘Rules of Practice 

for Domestic Licensing Proceedings and 

Issuance of Orders,’’ and ‘‘Domestic 

Licensing of Production and Utilization 

Facilities,’’ notice is hereby given that a 

hearing will be held, at a time and place 

to be set in the future by the 

Commission or designated by the 

Atomic Safety and Licensing Board 

(Board). 

The hearing on the application for a 

construction permit filed by SHINE 

pursuant to 10 CFR part 50 will be 

conducted by a Board that will be 

designated by the Chief Judge of the 

Atomic Safety and Licensing Board 

Panel or will be conducted by the 

Commission. Notice as to the 

membership of the Board will be 

published in the Federal Register at a 

later date. The NRC staff will complete 

a detailed technical review of the 

application and will document its 

findings in a safety evaluation report. 

The Commission will refer a copy of the 

application to the Advisory Committee 

on Reactor Safeguards (ACRS) in 

accordance with 10 CFR 50.58, 

‘‘Hearings and Report of the Advisory 

Committee on Reactor Safeguards,’’ and 

the ACRS will report on those portions 

of the application that concern safety. 

The NRC staff will also complete an 

environmental review of the application 

and will document its findings in an 

environmental impact statement in 

accordance with the National 

Environmental Policy Act of 1969, as 

amended, and the Commission’s 

regulations in 10 CFR part 51. 

III. Opportunity To Petition for Leave 

To Intervene 

Within 60 days after the date of 

publication of this Federal Register 

notice, any person whose interest may 

be affected by this proceeding and who 

desires to participate as a party in this 

proceeding must file a written petition 

for leave to intervene with respect to 

issuance of the construction permit to 

SHINE in accordance with the NRC’s 

‘‘Agency Rules of Practice and 

Procedure’’ in 10 CFR part 2. Interested 


asabaliauskas on DSK5VPTVN1PROD with NOTICES